Investigation of the Impact of Medications Used in COVID-19 Treatment and COVID-19 Vaccine on Hearing

Zonguldak Bulent Ecevit University

Status: Completed

Conditions: Hearing; Ototoxicity; COVID - 19

Treatments: Diagnostic Test: Hearing tests

Study type: Observational

Funder types: Other

Identifiers

NCT07254442

2021/61-18

1919B012102481 (Other Grant/Funding Number)

Details and patient eligibility

About

Investigation of the Impact of Medications Used in COVID-19 Treatment and COVID-19 Vaccine on Hearing

Full description

This study aims to investigate the impact of medications containing the active ingredients hydroxychloroquine and favipiravir on the auditory system, as well as to examine the effect of COVID-19 on hearing and its potential relationship with medication use and COVID-19 vaccine dose.

Enrollment: 90 patients

Sex: All

Ages: 18 to 35 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

Age between 18 and 35 For the Medication group: Having had COVID-19 and using COVID-19 medications For the Non-Medication group: Having had COVID-19 and not using COVID-19 medications For the Control group: Having never had COVID-19

Exclusion criteria

Previously diagnosed with hearing loss Use of ototoxic medications other than those specified Pathology detected during tympanometric evaluation or otoscopic examination Chronic disease Family history of hearing loss History of meningitis Neurological disorders Acute or chronic ear infection Admission to intensive care

Trial design

90 participants in 3 patient groups

Control group

Description:

Group that has not had Covid-19

Treatment:

Diagnostic Test: Hearing tests

Medication Group

Description:

The group that had Covid-19 and used medication

Treatment:

Diagnostic Test: Hearing tests

Non-medication group

Description:

The group that had Covid-19 and did not use medication

Treatment:

Diagnostic Test: Hearing tests